These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 30638097)

  • 1. Validation of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy.
    Kindts I; Defraene G; Petillion S; Janssen H; Van Limbergen E; Depuydt T; Weltens C
    Acta Oncol; 2019 Apr; 58(4):448-455. PubMed ID: 30638097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy.
    Kindts I; Defraene G; Laenen A; Petillion S; Van Limbergen E; Depuydt T; Weltens C
    Acta Oncol; 2018 Jul; 57(7):916-923. PubMed ID: 29652212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of Patient-Reported Aesthetic Outcome Over Time and Identification of Factors Characterizing Poor Aesthetic Outcome After Breast-Conserving Therapy: Long-Term Results of a Prospective Cohort Study.
    Hennigs A; Biehl H; Rauch G; Golatta M; Tabatabai P; Domschke C; Schott S; Wallwiener M; Schütz F; Sohn C; Heil J
    Ann Surg Oncol; 2016 May; 23(5):1744-51. PubMed ID: 26545376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of brachytherapy and external beam radiotherapy boost in breast-conserving therapy: Patient-reported outcome measures and aesthetic outcome.
    Kindts I; Laenen A; Christiaens M; Janssen H; Van Limbergen E; Weltens C
    Strahlenther Onkol; 2019 Jan; 195(1):21-31. PubMed ID: 30140943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complication probability model for subcutaneous fibrosis based on published data of partial and whole breast irradiation.
    Avanzo M; Stancanello J; Trovò M; Jena R; Roncadin M; Trovò MG; Capra E
    Phys Med; 2012 Oct; 28(4):296-306. PubMed ID: 22119271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aesthetic outcome following breast-conserving surgery assessed by three evaluation modalities in relation to health-related quality of life.
    Dahlbäck C; Ringberg A; Manjer J
    Br J Surg; 2019 Jan; 106(1):90-99. PubMed ID: 30160774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery.
    Tommasino F; Durante M; D'Avino V; Liuzzi R; Conson M; Farace P; Palma G; Schwarz M; Cella L; Pacelli R
    Acta Oncol; 2017 May; 56(5):730-736. PubMed ID: 28281862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROMs following breast-conserving therapy for breast cancer: results from a prospective longitudinal monocentric study.
    Kindts I; Laenen A; van den Akker M; Weltens C
    Support Care Cancer; 2019 Nov; 27(11):4123-4132. PubMed ID: 30790047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factors.
    Hille-Betz U; Vaske B; Bremer M; Soergel P; Kundu S; Klapdor R; Hillemanns P; Henkenberens C
    Strahlenther Onkol; 2016 Jan; 192(1):8-16. PubMed ID: 26416291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
    Zehentmayr F; Söhn M; Exeli AK; Wurstbauer K; Tröller A; Deutschmann H; Fastner G; Fussl C; Steininger P; Kranzinger M; Belka C; Studnicka M; Sedlmayer F
    Radiat Oncol; 2015 May; 10():121. PubMed ID: 26018527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients.
    Pastore F; Conson M; D'Avino V; Palma G; Liuzzi R; Solla R; Farella A; Salvatore M; Cella L; Pacelli R
    Acta Oncol; 2016; 55(4):466-73. PubMed ID: 26623532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cardiac and pulmonary complication probabilities after radiation therapy for patients with early-stage breast cancer.
    Utehina O; Popovs S; Purina D; Slosberga I; Vevere I; Emzins D; Berzins J; Valuckas KP; Janulionis E; Miller A
    Medicina (Kaunas); 2009; 45(4):276-85. PubMed ID: 19423958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.
    Wijsman R; Dankers F; Troost EG; Hoffmann AL; van der Heijden EH; de Geus-Oei LF; Bussink J
    Radiother Oncol; 2015 Oct; 117(1):49-54. PubMed ID: 26341608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Web-Based IBTR! 2.0 Nomogram to Predict for Ipsilateral Breast Tumor Recurrence After Breast-Conserving Therapy.
    Kindts I; Laenen A; Peeters S; Janssen H; Depuydt T; Nevelsteen I; Van Limbergen E; Weltens C
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1477-1484. PubMed ID: 27315662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of 3D images in the aesthetic evaluation of breast cancer conservative treatment. Results from a prospective multicentric clinical trial.
    Cardoso MJ; Vrieling C; Cardoso JS; Oliveira HP; Williams NR; Dixon JM; ;
    Breast; 2018 Oct; 41():19-24. PubMed ID: 29940498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™.
    Dahlbäck C; Ullmark JH; Rehn M; Ringberg A; Manjer J
    Breast Cancer Res Treat; 2017 Aug; 164(3):679-687. PubMed ID: 28536951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric factors and Lyman normal-tissue complication modelling analysis for predicting radiation-induced lung injury in postoperative breast cancer radiotherapy: a prospective study.
    Zhou ZR; Han Q; Liang SX; He XD; Cao NY; Zi YJ
    Oncotarget; 2017 May; 8(20):33855-33863. PubMed ID: 27806340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
    Rodríguez N; Sanz X; Dengra J; Foro P; Membrive I; Reig A; Quera J; Fernández-Velilla E; Pera Ó; Lio J; Lozano J; Algara M
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1051-7. PubMed ID: 24161420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
    Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
    Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.